Clinical News
eMediNexus Coverage from: 
Lusutrombopag approved by EMA for thrombocytopenia in adults with liver
eMediNexus,  16 December 2018
remove_red_eye 574 Views
#Gastroenterology #Internal Medicine #Pharmacist

0 Read Comments                

The European Medicine Agencys (EMAs) Committee for Medicinal Products for Human Use has approved the thrombopoietin receptor agonist Lusutrombopag Shionogi for the treatment of severe thrombocytopenia in adults with chronic liver disease who are to undergo an invasive procedure.It reduces the need for platelet transfusions before primary invasive procedures and can be used for rescue therapy in the event of bleeding during the 7 days after such procedures.
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!